# DESCRIPTION

## TECHNICAL FIELD OF THE INVENTION

- define technical field

## STATEMENT OF FEDERALLY FUNDED RESEARCH

- state funding

## BACKGROUND OF THE INVENTION

- motivate fusion proteins
- summarize prior art

## SUMMARY OF THE INVENTION

- introduce TB vaccine composition
- describe antigen delivery to DCs
- motivate humoral and cellular immune responses
- describe method for increasing antigen presentation
- isolate and purify DC-specific antibody
- attach or conjugate antigens to antibody
- contact APC with antibody-antigen complex
- specify APC types
- list M. tuberculosis antigens
- specify DC-specific antibody or fragment
- describe immunostimulatory composition
- list M. tuberculosis antigens again
- specify DC-specific antibody or fragment again
- describe vaccine composition
- specify flexible linker
- describe tuberculosis vaccine composition
- introduce method for increasing effectiveness of dendritic cells
- describe steps of method
- introduce immunostimulation method
- describe steps of immunostimulation method
- specify bacterial disease
- describe antigens
- describe DC-specific antibody or fragment
- introduce method for treatment or prophylaxis against tuberculosis
- describe steps of method
- describe vaccine composition
- describe flexible linker
- describe conjugation of antigens
- describe DC-specific antibody or fragment
- introduce immunostimulatory composition
- describe composition
- describe administration of composition
- introduce tuberculosis vaccine
- describe vaccine composition
- describe administration of vaccine
- describe method for treatment or prophylaxis against tuberculosis
- describe vaccine composition

## DETAILED DESCRIPTION OF THE INVENTION

- introduce invention scope
- define terms
- define Antigen Presenting Cells (APC)
- define dendritic cells (DCs)
- define dendritic cell binding proteins
- define vaccine composition
- define antigen
- define antibodies
- define adjuvant
- define gene
- define nucleic acid
- define amino acid
- define polypeptide
- define protein
- define in vivo
- define in vitro
- define treatment
- introduce tuberculosis (TB) vaccine
- describe TB vaccine composition
- motivate need for TB vaccine
- describe dendritic cells (DCs) function
- describe pathogen recognition receptors (PRRs)
- describe DC maturation process
- describe inventors' hypothesis
- introduce DC-targeting vaccine generation
- introduce TB vaccine construction
- select antigens
- describe vaccine composition
- fuse antigens to recombinant mAb
- describe vaccine evaluation
- test vaccine candidates
- assess immune recall response
- demonstrate vaccine efficacy
- provide non-limiting examples of DC-specific antibodies
- show expression of constructs
- contemplate implementation of embodiments
- discuss scope of invention
- incorporate publications and patent applications by reference
- define terms used in claims
- discuss use of "a" or "an" in claims
- discuss use of "or" in claims
- discuss use of "about" in application
- define "comprising" and similar terms
- define "or combinations thereof"
- discuss scope of invention and variations

